2000
DOI: 10.1080/000486700642
|View full text |Cite
|
Sign up to set email alerts
|

An open label trial of venlafaxine in war veterans with chronic post traumatic stress disorder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Second-generation, dual-acting antidepressants such as venlafaxine and mirtazepine are widely used in treating major depression and other anxiety disorders, but have less empirical data demonstrating their efficacy for the specific treatment of PTSD (Chung et al, 2004;Connor, Davidson, Weisler, & Ahearn, 1999;Davidson et al, 2003;Hopwood et al, 2000;Smajkic et al, 2001). They are often considered as a second-line treatment in patients who have failed to respond to a trial of an SSRI.…”
Section: Pharmacological Managementmentioning
confidence: 99%
“…Second-generation, dual-acting antidepressants such as venlafaxine and mirtazepine are widely used in treating major depression and other anxiety disorders, but have less empirical data demonstrating their efficacy for the specific treatment of PTSD (Chung et al, 2004;Connor, Davidson, Weisler, & Ahearn, 1999;Davidson et al, 2003;Hopwood et al, 2000;Smajkic et al, 2001). They are often considered as a second-line treatment in patients who have failed to respond to a trial of an SSRI.…”
Section: Pharmacological Managementmentioning
confidence: 99%
“…Second-generation, dual acting antidepressants such as venlafaxine and mirtazepine, are widely used in treating major depression and other anxiety disorders but have less Table 1. Dosage and common side effects of drugs used to treat PTSD (adapted from Current Concepts in Pharmacotherapy for PTSD, Schoenfeld et al, 2004) empirical data demonstrating their efficacy for the specific treatment of PTSD (Hopwood et al, 2000, Smajkic et al, 2001, Davidson et al, 2003, Chung et al, 2004. They are often considered as a second-line treatment in patients who have failed to respond to a trial of an SSRI.…”
Section: Pharmacological Managementmentioning
confidence: 99%
“…In Canada, only paroxetine has Health Canada approval for the treatment of PTSD. Second-generation, dual acting antidepressants such as venlafaxine and mirtazepine, are widely used in treating major depression and other anxiety disorders but have less empirical data demonstrating their efficacy for the specific treatment of PTSD (Hopwood et al, 2000, Smajkic et al, 2001, Chung et al, 2004. They are often considered as a second-line treatment in patients who have failed to respond to a trial of an SSRI.…”
Section: Pharmacological Managementmentioning
confidence: 99%